Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
University Hospitals Expands ESO Service Arrangement to Deliver Prehospital Intelligence Across Northern Ohio
GlobeNewswire, Inc.
CLEVELAND, Oct. 07, 2026 (GLOBE NEWSWIRE) -- University Hospitals (UH), the Cleveland-based health system serving patients across northern Ohio, has expanded its partnership with ESO, a leading data services and software provider for fire...
Kubbco releases new controversial new breast-health film
EIN Presswire
A question you shouldn’t ask. A conversation we can’t avoid.
Disposable Medical Device Market to Reach USD 144.85 Billion by 2030, Growing at a CAGR of 4.9% – MarketsandMarkets™
GlobeNewswire, Inc.
Delray Beach, FL , Oct. 05, 2026 (GLOBE NEWSWIRE) -- MarketsandMarkets™ projects the global disposable medical devices market to grow from USD 113.95 billion in 2025 to USD 144.85 billion by 2030, at a CAGR of 4.9% during the forecast period....
BBP-418 Demonstrates Potential to Be Disease Modifying Therapy, Restoring Cardiac and Disease Markers to Unaffected Levels
GlobeNewswire, Inc.
- In exploratory analyses at Month 12, among individuals with LGMD2I/R9 (FKRP-related) with elevated HS troponin I at baseline, 100% treated with BBP-418 returned to the normal range by Month 12 versus 40% in the placebo arm (p=0.0248); HS...
Zealand Pharma announces Boehringer Ingelheim’s survodutide achieves up to 13.1% weight loss in new Phase III trial, alongside significant improvements in glycemic control in people with obesity and type 2 diabetes
GlobeNewswire, Inc.
Company announcement – No. 52 / 2026 Zealand Pharma announces Boehringer Ingelheim’s survodutide achieves up to 13.1% weight loss in new Phase III trial, alongside significant improvements in glycemic control in people with obesity and type 2...
King’s College Hospital London - Dubai Breaks Ground on Major Hospital Expansion
EIN Presswire
Phase 2 expansion will increase the hospital to 200 beds and further develop specialist and complex care services in Dubai DUBAI, UNITED ARAB EMIRATES, September 30, 2026 /EINPresswire.com/ -- Phase 2 expansion will increase the hospital to 200...
Pet Anxiety Awareness Day Launches in Europe October 12 supported by Orion Pharma Animal Health
EIN Presswire
New veterinary-focused initiative brings a decade of U.S. education on fear, anxiety, and stress (FAS) in companion animals to European veterinary clinics TAMPA, FL, UNITED STATES, September 30, 2026 /EINPresswire.com/ -- Pet Anxiety Awareness...
Allarity Provides Update on Key Recent Advances Solidifying Drug Response Predictor® to Drive Stenoparib’s Clinical Development
GlobeNewswire, Inc.
- Recently awarded patents have solidified Allarity’s strategy to leverage DRP to ensure the commercial exclusivity of stenoparib TARPON SPRINGS, Fla., September 30, 2026 – Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR),...
Zealand Pharma to present additional data from Phase 2 ZUPREME-1 trial for petrelintide at EASD 2026 and announces publication of trial results in The Lancet Diabetes & Endocrinology
GlobeNewswire, Inc.
Press release – No. 18 / 2026 Zealand Pharma to present additional data from Phase 2 ZUPREME-1 trial for petrelintide at EASD 2026 and announces publication of trial results in The Lancet Diabetes & Endocrinology Treatment with petrelintide was...
Novo and Hengrui Pharma enter exclusive license agreement for once-weekly oral GLP-1/GIP dual receptor agonist HRS-1596
GlobeNewswire, Inc.
HRS-1596 is a phase 1-ready GLP-1/GIP dual receptor agonist for once-weekly oral dosing Total potential deal value is up to 2.6 billion US dollars, including 300 million dollars upfront, as well as potential sales royalties Bagsværd, Denmark, 29...
AB Science provides an update on its development plan and financial calendar following a sponsor Good Clinical Practice inspection
GlobeNewswire, Inc.
PRESS RELEASE AB SCIENCE PROVIDES AN UPDATE ON ITS DEVELOPMENT PLAN AND FINANCIAL CALENDAR FOLLOWING A SPONSOR GOOD CLINICAL PRACTICE INSPECTION Confirmation of the relevance of having, among the first decisions of the new management, given...
New Preprint: Engineered On-Board Hypoxic Living Environments for Astronaut Health and Deep-Space Radiation Protection
EIN Presswire
Research effort led by Biogerontology Research Foundation with coauthors from NASA Johnson Space Center, Cedars-Sinai, Broad Institute of MIT & Harvard & others LONDON, UNITED KINGDOM, September 29, 2026 /EINPresswire.com/ -- The Biogerontology...
Zealand Pharma - Transactions related to share buy-back program (week 39, 2026)
GlobeNewswire, Inc.
Company announcement No. 50 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 39, 2026) Copenhagen, Denmark, September 28, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078),...
Lift Therapeutics Appoints Eva Ehrnrooth as Executive Head of Clinical Development and Adds Chau Khuong to Board of Directors
GlobeNewswire, Inc.
London, September 28, 2026 – Lift Therapeutics (‘Lift’ or ‘the Company’) today announced the appointment of Eva Ehrnrooth, MD, PhD, as Executive Head of Clinical Development and Chau Khuong to its Board of Directors.
Ten Reputable Bulk Freeze Dried Fruit Manufacturers in 2026: Driving Global Healthy Food Innovations
EIN Presswire
This report highlights reputable suppliers serving global food, beverage, and nutrition brands with consistent bulk freeze-dried fruit ingredients.
Ascendis to Share Latest Advances in Hypoparathyroidism and Achondroplasia Programs at ASBMR 2026
GlobeNewswire, Inc.
COPENHAGEN, Denmark, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that the latest advances in its hypoparathyroidism and achondroplasia programs will be showcased during ASBMR 2026, the annual meeting of...
Fort Carson community participates in first Danish Flyver Ruck March
DVIDS - Georgia
More than 560 people from the Fort Carson military community recently participated in the Danish Flyver Ruck March.
Flen Health Chooses AGC Biologics to Manufacture Recombinant Enzymes for Next-Generation Wound Treatment
GlobeNewswire, Inc.
HEIDELBERG, Germany, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Belgian biopharmaceutical company Flen Health has selected AGC Biologics as their CDMO partner to provide process development, scale-up, and GMP manufacturing services for a new and improved...
Countries and partners commit more than US$715 million for reproductive health
GlobeNewswire, Inc.
New York, Sept. 24, 2026 (GLOBE NEWSWIRE) -- UK announces £254 million (US$337.8 million) for reproductive health GiveWell makes its first investment in UNFPA with a US$10 million grant Burundi, Madagascar, Mozambique, and Zimbabwe commit more...
Breye Therapeutics has a paper on its oral danegaptide treatment for patients with NPDR published in Science Translational Medicine
GlobeNewswire, Inc.
Oral treatment danegaptide represents “a potential paradigm shift” toward earlier, non-invasive treatment of Non-Proliferative Diabetic Retinopathy (NPDR), say authors Study “provides compelling evidence” that danegaptide robustly protects inner...
Sign up for:
Healthcare Times Denmark
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.